在来那度胺治疗AL淀粉样变性过程中B型利钠肽（BNP）升高。 - Suppr

Increases in B-type natriuretic peptide (BNP) during treatment with lenalidomide in AL amyloidosis.

作者信息

Tapan Umit, Seldin David C, Finn Kathleen T, Fennessey Salli, Shelton Anthony, Zeldis Jerome B, Sanchorawala Vaishali

出版信息

Blood. 2010 Dec 2;116(23):5071-2. doi: 10.1182/blood-2010-09-305136.

DOI:10.1182/blood-2010-09-305136

PMID:21127185

Abstract

摘要

相似文献

Increases in B-type natriuretic peptide (BNP) during treatment with lenalidomide in AL amyloidosis.

Blood. 2010 Dec 2;116(23):5071-2. doi: 10.1182/blood-2010-09-305136.

Durable hematologic complete responses can be achieved with lenalidomide in AL amyloidosis.

Blood. 2010 Sep 16;116(11):1990-1. doi: 10.1182/blood-2010-07-295485.

Salvage therapy with lenalidomide and dexamethasone in patients with advanced AL amyloidosis refractory to melphalan, bortezomib, and thalidomide.

Ann Hematol. 2012 Jan;91(1):89-92. doi: 10.1007/s00277-011-1244-x. Epub 2011 Apr 30.

A phase 1/2 study of lenalidomide with low-dose oral cyclophosphamide and low-dose dexamethasone (RdC) in AL amyloidosis.

Blood. 2012 Jun 7;119(23):5384-90. doi: 10.1182/blood-2011-12-396903. Epub 2012 Apr 18.

Lenalidomide in the treatment of plasma cell dyscrasia: state of the art and perspectives.

Haematologica. 2013 May;98(5):660-1. doi: 10.3324/haematol.2013.084871.

[Treatment of AL amyloidosis in 2012; the benefit of new drugs (bortezomib, thalidomide, and lenalidomide). Summary of published clinical trials].

Vnitr Lek. 2013 Jan;59(1):37-58.

The evolving role of lenalidomide in the treatment of hematologic malignancies.

Expert Opin Pharmacother. 2007 Mar;8(4):497-509. doi: 10.1517/14656566.8.4.497.

Treatment of plasma cell dyscrasias with lenalidomide.

Leukemia. 2008 Jul;22(7):1343-53. doi: 10.1038/leu.2008.123. Epub 2008 May 29.

Changes in cardiac biomarkers with bortezomib treatment in patients with advanced cardiac amyloidosis.

Am J Hematol. 2015 Nov;90(11):E212-3. doi: 10.1002/ajh.24176. Epub 2015 Oct 6.

[Current treatment of AL amyloidosis].

Nephrol Ther. 2011 Nov;7(6):467-73. doi: 10.1016/j.nephro.2011.02.003. Epub 2011 Apr 15.

引用本文的文献

Outcomes of daratumumab-bortezomib-thalidomide-dexamethasone in treatment-naive systemic AL amyloidosis.

Br J Haematol. 2025 Apr;206(4):1141-1148. doi: 10.1111/bjh.20021. Epub 2025 Feb 21.

Cardiovascular toxicity from therapies for light chain amyloidosis.

Front Cardiovasc Med. 2023 Jul 5;10:1212983. doi: 10.3389/fcvm.2023.1212983. eCollection 2023.

Nomogram Model for Dynamic and Individual Prediction of Cardiac Response and Survival for Light Chain Amyloidosis in 737 Patients With Cardiac Involvement.

Front Oncol. 2021 Dec 9;11:758502. doi: 10.3389/fonc.2021.758502. eCollection 2021.

AL Amyloidosis for the Cardiologist and Oncologist: Epidemiology, Diagnosis, and Management.

JACC CardioOncol. 2019 Sep 24;1(1):117-130. doi: 10.1016/j.jaccao.2019.08.002. eCollection 2019 Sep.

Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021.

Blood Cancer J. 2021 May 15;11(5):90. doi: 10.1038/s41408-021-00483-7.

Bendamustine With Dexamethasone in Relapsed/Refractory Systemic Light-Chain Amyloidosis: Results of a Phase II Study.

J Clin Oncol. 2020 May 1;38(13):1455-1462. doi: 10.1200/JCO.19.01721. Epub 2020 Feb 21.

Treatment Options For Relapsed/refractory Systemic Light-Chain (AL) Amyloidosis: Current Perspectives.

J Blood Med. 2019 Oct 23;10:373-380. doi: 10.2147/JBM.S183857. eCollection 2019.

Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis.

JACC Basic Transl Sci. 2019 Jun 24;4(3):438-448. doi: 10.1016/j.jacbts.2019.02.002. eCollection 2019 Jun.

Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2018.

Blood Cancer J. 2018 May 23;8(5):44. doi: 10.1038/s41408-018-0080-9.

Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up.

Haematologica. 2017 Aug;102(8):1424-1431. doi: 10.3324/haematol.2016.163246. Epub 2017 May 18.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Increases in B-type natriuretic peptide (BNP) during treatment with lenalidomide in AL amyloidosis.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献